Overall survival analysis revealed that HCC patients with high levels of RelA (HR = 1.6, P = 0.0055), RelB (HR = 1.5, P = 0.024), and NF-κB2 (HR = 1.6, P = 0.0058) had a poor overall survival rates. This evidence concerns the gene RELB and hepatocellular carcinoma.